Prostate cancer risk after TURP ‘low’ for men with PSA levels <10ng/mL
A large database study identifies the cut-point warranting increased surveillance
Men with PSA levels below 10ng/mL at time of surgical treatment for benign prostatic hyperplasia are at low risk of aggressive cancer, a large population-based study shows.
Danish researchers say their results should reassure clinicians that, in the absence of any red flags, patients who fall into this category do not need to be monitored differently than other men.
